Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 1306 to 1320 of 1835 results for carers

  1. What is the optimal way of discharging people approaching the end of their life from hospitals back to their place of residence?

    discharge can be distressing to the person approaching the end of life and their carers and important people. It could mean people...

    Research recommendation
    Published
    18 November 2019

  2. Care and support for people with dementia:- What is the effect of specific interventions to support people with dementia during transition between inpatient mental health settings and community or care home settings?

    exploring views and experiences of people with dementia and their families and carers would also be welcome. Source guidance details...

    Research recommendation
    Published
    17 October 2016

  3. Coeliac disease (QS134)

    This quality standard covers recognising, assessing and managing coeliac disease in adults, young people and children. It describes high-quality care in priority areas for improvement.

    Quality standard
    Published
    19 October 2016
    View quality statements

    Sections for QS134

  4. Is an integrated care system effective at promoting successful progress for people with complex psychosis to a more independent setting?

    integrated system was a team of health and social care practitioners and informal carers for each person who met weekly to coordinate...

    Research recommendation
    Published
    26 October 2020

  5. People in eligible groups:- What are the important messages and how should they be tailored and delivered to encourage and sustain flu vaccination uptake in eligible groups?

    and how they want to be involved in decision-making. This might include carers and other decision-makers. Interventions may need to be...

    Research recommendation
    Published
    12 December 2018

  6. RT300 for spinal cord injury rehabilitation (MIB169)

    NICE has developed a medtech innovation briefing (MIB) on RT300 for spinal cord injury rehabilitation .

    Medtech innovation briefing
    Published
    16 January 2019

  7. The evidence on the safety of transurethral laser ablation for recurrent non-muscle-invasive bladder cancer shows that there are no major safety concerns. However, current evidence on its efficacy is limited in quality and quantity. Therefore, this procedure should only be used with  special arrangements   for clinical governance, consent, and audit or research.

    governance leads in their NHS trusts. Ensure that patients and their carers understand the uncertainty about the procedure's safety and...

    Research recommendation
    Published
    15 November 2019

  8. What is the clinical and cost effectiveness, post-treatment and at longer-term follow‑up, of a brief psychosocial intervention as reported by the IMPACT trial, but delivered by practitioners other than psychiatrists and in other settings, including primary care, to young people aged 12 to 18 years with mild or moderate to severe depression?

    the committee agreed that children and young people and their families or carers should be empowered to take part in shared decision...

    Research recommendation
    Published
    25 October 2019

  9. What is the clinical and cost effectiveness, post-treatment and at longer-term follow‑up, of family therapy, psychodynamic psychotherapy and interpersonal psychotherapy for adolescents (IPT‑A) compared with each other and with individual CBT in young people aged 12 to 18 years with moderate to severe depression?

    the committee agreed that children and young people and their families or carers should be empowered to take part in shared decision...

    Research recommendation
    Published
    25 October 2019

  10. What is the clinical and cost effectiveness, post-treatment and at longer-term follow‑up, of psychological therapies in children aged 5 to 11 years with mild or moderate to severe depression?

    the committee agreed that children and young people and their families or carers should be empowered to take part in shared decision...

    Research recommendation
    Published
    25 October 2019

  11. Tafasitamab with lenalidomide for treating relapsed or refractory diffuse large B-cell lymphoma (TA883)

    Evidence-based recommendations on tafasitamab (Minjuvi) with lenolidomide for relapsed or refractory diffuse large B-cell lymphoma in adults who cannot have an autologous stem cell transplant.

    Technology appraisal guidance
    Published
    3 May 2023
    View recommendations

    Sections for TA883

  12. Screening assessment tools:- Develop reliable and valid screening assessment tools for attachment and sensitivity that can be made available and used in routine health, social care and education settings.

    can measure the sensitivity of parenting (by biological parents and new carers and adoptive parents) in relation to the child (of any...

    Research recommendation
    Published
    11 December 2015

  13. Interventions to reduce the frequency and extent of moderate to severe behaviour that challenges in community settings:- Are interventions based on the science and practice of applied behaviour analysis or antipsychotic medication, or a combination of these, effective in reducing the frequency and severity of behaviour that challenges shown by adults with a learning disability?

    disability and can have a considerable impact on them and their family members or carers. It is also a common reason for hospital or...

    Research recommendation
    Published
    5 October 2015

  14. VA ECMO for severe acute heart failure in adults (HTG764)

    Evidence-based recommendations on venoarterial extracorporeal membrane oxygenation (VA ECMO) for severe acute heart failure in adults. This involves using an artificial lung to oxygenate the blood outside the body.

    HealthTech guidance
    Published
    22 October 2025
    View recommendations

    Sections for HTG764

  15. Psoriasis (QS40)

    This quality standard covers assessing and managing psoriasis in adults, young people and children. It describes high-quality care in priority areas for improvement.

    Quality standard
    Published
    6 August 2013
    View quality statements

    Sections for QS40